⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

June 29, 2021The Lancet Diabetes & EndocrinologyOpen Access

Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Juvenile Research Diabetes Foundation.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Gitelman et al. (2021) studied this question.

synapsesocial.com/papers/69dd61ca80eea7d3f699c54c https://doi.org/10.1016/s2213-8587(21)00139-x

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

1The development of imatinib as a therapeutic agent for chronic myeloid leukemiaClinical Trial · 2004 · 1,258 citations
2Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity.Original Research · 2000 · 1,047 citations
3Amelioration of diabetes by imatinib mesylate (Gleevec®): role of ‐cell NF‐KB activation and anti‐apoptotic preconditioningOriginal Research · 2006 · 132 citations
4PPARγ Antagonist Gleevec Improves Insulin Sensitivity and Promotes the Browning of White Adipose TissueOriginal Research · 2016 · 97 citations